Therefore, the goal of the current study was to assess the effects of long-term treatment with the GLP-1 analogue Liraglutide on endothelial in patients with type 2 diabetes using a multicenter, prospective randomized parallel-group comparison study design. This evidence concerns the gene GCG and type 2 diabetes mellitus.